These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35748083)

  • 1. Positive rate-dependent action potential prolongation by modulating potassium ion channels.
    Cabo C
    Physiol Rep; 2022 Jun; 10(12):e15356. PubMed ID: 35748083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multichannel modulation of depolarizing and repolarizing ion currents increases the positive rate-dependent action potential prolongation.
    Cabo C
    Physiol Rep; 2023 May; 11(9):e15683. PubMed ID: 37144560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
    Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
    Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes.
    Gintant GA
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):945-53. PubMed ID: 9641481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.
    Hondeghem LM; Carlsson L; Duker G
    Circulation; 2001 Apr; 103(15):2004-13. PubMed ID: 11306531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation.
    Groh WJ; Gibson KJ; Maylie JG
    J Cardiovasc Electrophysiol; 1997 May; 8(5):529-36. PubMed ID: 9160229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study.
    Viswanathan PC; Shaw RM; Rudy Y
    Circulation; 1999 May; 99(18):2466-74. PubMed ID: 10318671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of rate-dependent shortening of action potential duration in guinea-pig ventricle; effects of IK1 and IKr blockade.
    Williams BA; Dickenson DR; Beatch GN
    Br J Pharmacol; 1999 Mar; 126(6):1426-36. PubMed ID: 10217537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization.
    Zeng J; Laurita KR; Rosenbaum DS; Rudy Y
    Circ Res; 1995 Jul; 77(1):140-52. PubMed ID: 7788872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
    Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of potassium channels to action potential repolarization of human embryonic stem cell-derived cardiomyocytes.
    Wang Y; Zhu R; Tung L
    Br J Pharmacol; 2019 Aug; 176(15):2780-2794. PubMed ID: 31074016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of frequency-dependent protocols in antiarrhythmic and proarrhythmic drug testing.
    Nánási PP; Szabó Z; Kistamás K; Horváth B; Virág L; Jost N; Bányász T; Almássy J; Varró A
    Prog Biophys Mol Biol; 2020 Nov; 157():76-83. PubMed ID: 31726065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of physiological late Na
    El-Bizri N; Li CH; Liu GX; Rajamani S; Belardinelli L
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H236-H245. PubMed ID: 28971840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.
    Varro A; Baláti B; Iost N; Takács J; Virág L; Lathrop DA; Csaba L; Tálosi L; Papp JG
    J Physiol; 2000 Feb; 523 Pt 1(Pt 1):67-81. PubMed ID: 10675203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation.
    Volders PG; Stengl M; van Opstal JM; Gerlach U; Spätjens RL; Beekman JD; Sipido KR; Vos MA
    Circulation; 2003 Jun; 107(21):2753-60. PubMed ID: 12756150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide.
    Jurkiewicz NK; Sanguinetti MC
    Circ Res; 1993 Jan; 72(1):75-83. PubMed ID: 8417848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve.
    Biliczki P; Virág L; Iost N; Papp JG; Varró A
    Br J Pharmacol; 2002 Oct; 137(3):361-8. PubMed ID: 12237256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action potential prolongation by RP 58866 and its active enantiomer, terikalant. Block of the rapidly activating delayed rectifier K+ current, IKr.
    Jurkiewicz NK; Wang J; Fermini B; Sanguinetti MC; Salata JJ
    Circulation; 1996 Dec; 94(11):2938-46. PubMed ID: 8941124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of cardiac potassium channels.
    Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
    Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of reverse rate-dependent action of cardioactive agents.
    Bányász T; Bárándi L; Harmati G; Virág L; Szentandrássy N; Márton I; Zaza A; Varró A; Nánási PP
    Curr Med Chem; 2011; 18(24):3597-606. PubMed ID: 21774765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.